Gallogo, Jolly Mae .
HRN: 22-86-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/11/2023
04/13/2023
IV
500 Mg
Every 8 Hours For 3 Doses
S/P LSCS With IUD
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes